Response: Commentary: Chronic ssri stimulation of astrocytic 5-ht2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: A potential paradigm shift

Frontiers in Behavioral Neuroscience

Volumn 9, Issue NOVEMBER, 2015, Pages

  Hertz, Leif ^a   Rothman, Douglas L ^b   Li, Baoman ^a   Peng, Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b YALE UNIVERSITY   (United States)

Author keywords

5 HT2B receptor; Astrocytic transactivation; PLA2; Serotonin transporter; SSRIs

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM CHANNEL L TYPE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOXETINE; G PROTEIN COUPLED RECEPTOR; GLUCOSE; GLUTAMIC ACID; GLYCOGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOSIDE TRANSPORTER; PHOSPHOLIPASE A2; SEROTONIN 2B RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SMALL INTERFERING RNA;

AMINO ACID METABOLISM; ASTROCYTE; AUTOCRINE EFFECT; CELL STIMULATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GABAERGIC SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GLUCOSE METABOLISM; HUMAN; INTRACELLULAR SIGNALING; LONG TERM EXPOSURE; MAJOR DEPRESSION; MOLECULAR DYNAMICS; NONHUMAN; NOTE; PARACRINE SIGNALING; RNA EDITING; UPREGULATION;

EID: 84947721323     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00308     Document Type: Note

References (19)

1. 2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front. Behav. Neurosci. 9:207. doi: 10.3389/fnbeh.2015.00207
2. Diaz, S. L., Doly, S., Narboux-Nême, N., Fernández, S., Mazot, P., Banas, S. M., et al. (2012). 5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Mol. Psychiatry 17, 154-163. doi: 10.1038/mp.2011.159
3. Fields, R. D. (2009). The Other Brain: From Dementia to Schizophrenia, How New Discoveries about the Brain Are Revolutionizing Medicine and Science. New York, NY: Simon and Schuster
4. Hansson, E., and Rönnbäck, L. (2004). "Astrocytic receptors and second messenger systems," in Non-neuronal Cells of the Nervous System: Function and Dysfunction II, ed L. Hertz (Amsterdam: Elsevier), 475-501
5. 2B-mediated SERT-independent SSRI target, slowly altering depression- associated genes and function. Curr. Signal Transduct. Ther. 7, 65-80. doi: 10.2174/1574362799278154
6. 2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift. Front. Behav. Neurosci. 9:25. doi: 10.3389/fnbeh.2015.00025
7. Homberg, J. R., Olivier, J. D., Blom, T., Arentsen, T., van Brunschot, C., Schipper, P., et al. (2011). Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS ONE 6:e16646. doi: 10.1371/journal.pone.0016646
8. 2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 27, 113-120. doi: 10.1023/A:1014862808126
9. 2B receptor signaling in serotonergic neuronal cells. FASEB J. 20, 1843-1854. doi: 10.1096/fj.06-5724com
10. Li, B., Dong, L., Wang, B., Cai, L., Jiang, N., and Peng, L. (2012). Cell type- specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia. Neurochem. Res. 37, 2480-2495. doi: 10.1007/s11064-012-0814-1
11. 2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacol. (Berl.) 201, 443-458. doi: 10.1007/s00213-008-1306-5
12. 2B serotonergic signaling. Neurochem. Int. 57, 421-431. doi: 10.1016/j.neuint.2010.04.018
13. 2B receptors. Drug Dev. Res. 76, 31-39. doi: 10.1002/ddr.21238
14. Qiao, J., Wang, J., Wang, H., Zhang, Y., Zhu, S., Adilijiang, A., et al. (2015). Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model. Glia. doi: 10.1002/glia.22926. [Epub ahead of print]
15. Qu, Y., Chang, L., Klaff, J., Seemann, R., and Rapoport, S. I. (2003). Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats. Neuropsychopharmacology 28, 1219-1226. doi: 10.1038/sj.npp.1300177
16. Qu, Y., Villacreses, N., Murphy, D. L., and Rapoport, S. I. (2005). 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacol. (Berl.) 180, 12-20. doi: 10.1007/s00213-005-2231-5
17. Rainey, M. M., Korostyshevsky, D., Lee, S., and Perlstein, E. O. (2010). The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics 185, 1221-1233. doi: 10.1534/genetics.110.117846
18. Sarkar, A., Chachra, P., and Vaidya, V. A. (2014). Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation. mtry 76, 858-868. doi: 10.1016/j.biopsych.2013.11.005
19. 2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional ‘serotonin-specific reuptake inhibitors’. Neuron Glia. Biol. 6, 113-125. doi: 10.1017/S1740925X10000141